Woman's adrenal glands fail after using nasal spray for allergies
A 38-year-old woman, identified as Nhiên, has been diagnosed with adrenal insufficiency after regularly using a nasal spray to treat her allergic rhinitis. She presented with symptoms including rapid breathing and headaches. Doctors determined that her condition was a result of the prolonged use of the allergy medication.
Adrenal insufficiency, also known as Addison's disease, occurs when the adrenal glands do not produce enough of certain hormones. In this case, the corticosteroid in the nasal spray is believed to have suppressed the body's natural production of these hormones. This case highlights a potential risk associated with the overuse or long-term application of certain over-the-counter and prescription nasal sprays.
This case underscores the importance of understanding the systemic effects of topical medications, even those applied locally like nasal sprays. Prolonged use of corticosteroid-based nasal sprays can lead to HPA axis suppression, resulting in adrenal insufficiency. This phenomenon highlights a critical trade-off between symptom relief and potential long-term physiological disruption. Patients and healthcare providers must balance the benefits of allergy management against the risks of iatrogenic endocrine disorders, emphasizing judicious prescribing and patient education on the duration of use and potential side effects. Future considerations should include developing alternative treatments and enhancing patient monitoring protocols for chronic medication users.
AI-generated to prompt reflection — not editorial opinion, not advice, not a statement of fact. How this works.